Subjects With Hyperlipidemia, Dyslipidemia
1 clinical trials · Condition
◉ Watch Subjects With Hyperlipidemia, Dyslipidemia
| Record | Firm | Date |
|---|---|---|
| Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a)) (NCT02729025) | Amgen | 2016-04-14 |
Track Subjects With Hyperlipidemia, Dyslipidemia automatically
Every clearance here is in the API, with alerts when new ones post.